Search

Your search keyword '"University of Southampton [Southampton]"' showing total 302 results

Search Constraints

Start Over You searched for: Author "University of Southampton [Southampton]" Remove constraint Author: "University of Southampton [Southampton]" Topic neoplasms Remove constraint Topic: neoplasms
302 results on '"University of Southampton [Southampton]"'

Search Results

1. The experiences and decision making of patients with incurable cancer and health literacy difficulties.

2. Maintaining long-term physical activity after cancer: a conceptual framework to inform intervention development.

3. Changes in hospital mortality in patients with cancer during the COVID-19 pandemic (ISARIC-CCP-UK): a prospective, multicentre cohort study.

4. International consensus is needed on a core outcome set to advance the evidence of best practice in cancer prehabilitation services and research.

5. Cancer incidence, treatment, and survival in the prison population compared with the general population in England: a population-based, matched cohort study.

6. Prevalence of Preferences for End-of-Life Place of Care and Death Among Patients With Cancer in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis.

7. Cancer immunotherapy with immune checkpoint inhibitors and infections: A particular focus on mycobacterial infections.

8. Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and Challenges.

9. Identification and Development of Cyclic Peptide Inhibitors of Hypoxia Inducible Factors 1 and 2 That Disrupt Hypoxia-Response Signaling in Cancer Cells.

10. Study protocol for a pragmatic randomised controlled trial of comparing enhanced acceptance and commitment therapy plus (+) added to usual aftercare versus usual aftercare only, in patients living with or beyond cancer: SUrvivors' Rehabilitation Evaluation after CANcer (SURECAN) trial.

11. Capture-based targeted sequencing using a T-cell control in myeloid malignancies and idiopathic cytopenias.

12. Recommendations for laboratory workflow that better support centralised amalgamation of genomic variant data: findings from CanVIG-UK national molecular laboratory survey.

13. Patient and parent perspectives on paediatric cancer multidisciplinary team working and national advisory panels in the UK: a qualitative research study.

14. Charting cellular differentiation trajectories with Ricci flow.

15. Codesign of Lynch Choices TM : Using implementation science to create a clinically deliverable patient decision support website to transform cancer genetics care pathways.

16. Long-term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post-treatment.

17. Addressing cancer anorexia-cachexia in older patients: Potential therapeutic strategies and molecular pathways.

18. Aneuploidy and complex genomic rearrangements in cancer evolution.

19. Protocol for the development of a Core Outcome Set (COS) for Adolescents and Young Adults (AYAs) with cancer.

20. Barriers and facilitators to integrated cancer care between primary and secondary care: a scoping review.

21. Co-design of patient information leaflets for germline predisposition to cancer: recommendations for clinical practice from the UK Cancer Genetics Group (UKCGG), Cancer Research UK (CRUK) funded CanGene-CanVar Programme and the Association of Genetic Nurse Counsellors (AGNC).

22. Global trends in psycho-oncology research investments 2016-2020: A content analysis.

23. Perspectives on common chronic diseases in adult cancer patients in South Africa.

24. Exploration of pain assessment and management processes in oncology outpatient services with healthcare professionals: a qualitative study.

25. Tunnelled external versus implanted port central venous catheters in paediatric oncology: a systematic review and meta-analysis.

26. COPI vesicle formation and N-myristoylation are targetable vulnerabilities of senescent cells.

28. Integrated network pharmacology and cellular assay reveal the biological mechanisms of Limonium sinense (Girard) Kuntze against Breast cancer.

29. Transforming global approaches to chronic disease prevention and management across the lifespan: integrating genomics, behavior change, and digital health solutions.

31. Post-Operative Care of the Cancer Patient: Emphasis on Functional Recovery, Rapid Rescue, and Survivorship.

32. 'I think it affects every aspect of my life, really': Cancer survivors' experience of living with chronic pain after curative cancer treatment in England, UK.

33. Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY.

34. Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire.

35. Reactivation of low avidity tumor-specific CD8 + T cells associates with immunotherapeutic efficacy of anti-PD-1.

36. 'A real fine balancing act': A secondary qualitative analysis of power imbalance in comorbid cancer and dementia in an outpatient treatment setting.

37. A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP).

38. From cancer prevention to death: the case for transdiagnostic services for physical health in people with mental disorders.

39. Germline mismatch repair (MMR) gene analyses from English NHS regional molecular genomics laboratories 1996-2020: development of a national resource of patient-level genomics laboratory records.

40. Incident cardiovascular events and imaging phenotypes in UK Biobank participants with past cancer.

41. Sequence enrichment profiles enable target-agnostic antibody generation for a broad range of antigens.

42. Looking back: a review of policy implications for exercise oncology.

43. Programmed cell death-1 receptor-mediated regulation of Tbet + NK1.1 - innate lymphoid cells within the tumor microenvironment.

44. Transatlantic progress in measurement of cognitive outcomes in paediatric oncology trials.

45. Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy.

46. Delivering co-stimulatory tumor necrosis factor receptor agonism for cancer immunotherapy: past, current and future perspectives.

47. Towards a better understanding of human iNKT cell subpopulations for improved clinical outcomes.

48. Zwitterionic Targeting Doxorubicin -Loaded Micelles Assembled by Amphiphilic Dendrimers with Enhanced Antitumor Performance.

49. Updating our understanding of health-related quality of life issues in children with cancer: a systematic review of patient-reported outcome measures and qualitative studies.

50. PIP4K2B is mechanoresponsive and controls heterochromatin-driven nuclear softening through UHRF1.

Catalog

Books, media, physical & digital resources